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A randomized, single-blind 
cross-over design evaluating the 
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defined, targeted physical therapy 
approach in treatment of children 
with cerebral palsy
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Abstract
Objective: A pilot study to compare the effectiveness of an individual therapy program with the effects 
of a general physical therapy program.
Design: A randomized, single-blind cross-over design.
Participants: Ten ambulant children with bilateral spastic cerebral palsy, age four to nine years.
Intervention: Participants were randomly assigned into a ten-week individually defined, targeted or a 
general program, followed by a cross-over.
Main outcome measures: Evaluation was performed using the Gross Motor Function Measure-88 and 
three-dimensional gait analysis. General outcome parameters were Gross Motor Function Measure-88 scores, 
time and distance parameters, gait profile score and movement analysis profiles. Individual goal achievement 
was evaluated using z-scores for gait parameters and Goal Attainment Scale for gross motor function.
Results: No significant changes were observed regarding gross motor function. Only after individualized 
therapy, step- and stride-length increased significantly (p = 0.022; p = 0.017). Change in step-length was 
higher after the individualized program (p = 0.045). Within-group effects were found for the pelvis in 
transversal plane after the individualized program (p  =  0.047) and in coronal plane after the general 
program (p = 0.047). Between-program differences were found for changes in the knee in sagittal plane, 
in the advantage of the individual program (p = 0.047). A median difference in z-score of 0.279 and 0.419 
was measured after the general and individualized program, respectively. Functional goal attainment was 
higher after the individual therapy program compared with the general program (48 to 43.5).
Conclusion: The results indicate slightly favorable effects towards the individualized program. To detect 
clinically significant changes, future studies require a minimal sample size of 72 to 90 participants.
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Introduction
Many different techniques and approaches are 
available for physical therapy treatment of children 
with cerebral palsy.1 Although promising results 
are available for isolated physical therapy tech-
niques, evidence about the outcome of complete 
programs using a combination of different tech-
niques is more limited.2,3
Several research studies have evaluated the 
effects of goal-setting in physical therapy of chil-
dren with cerebral palsy.4–9 The results of a recent 
systematic review, however, could not provide sup-
port for the effectiveness of goal-setting within an 
activity-focused approach on treatment outcome.10 
The authors of this review found that none of the 
included studies were designed specifically to 
determine the effect of goal-setting per se, as goal-
setting was additional to guiding the interventions.
An important advantage of goal-oriented physi-
cal therapy however, is the potential benefit to 
enhance training specificity. Goal planning, in that 
context, can be used to identify the tasks and con-
texts of particular interest and thereby, to use a 
more targeted and focused approach.11
In a previous study, we developed and validated a 
clinical decision framework based on the hypothesis-
oriented algorithm for clinicians12 and the 
International Classification of Functioning, Disability 
and Health (ICF) for Children and Youth,13,14 
Organizing assessment results within the framework 
of the International Classification of Functioning 
provides a profound and complete overview of the 
child and results in an objective problem list for the 
child. In children with cerebral palsy, however, this 
list is generally very extensive. Therefore, as a thera-
pist, one has to prioritize and select possible and real-
istic targets in treatment. The hypothesis-oriented 
algorithm for clinicians provided this strategy-ori-
ented structure for clinical reasoning and was used to 
reduce the long problem list to a selection of main 
problems. The combined approach of both frame-
works was demonstrated as a positive structure that 
supported clinical reasoning in pediatric physical 
therapists.14
As a next step, a pilot study was set up to use 
this clinical reasoning structure in a controlled 
intervention. This study, therefore, aims to investi-
gate the effectiveness of an individually defined 
and targeted physical therapy approach using struc-
tured clinical reasoning on gait and gross motor 
function of ambulant children with bilateral spastic 
cerebral palsy. Using a randomized, repeated-
measures, cross-over design, the outcome of this 
approach is compared with the outcome of a gen-
eral program.
It is hypothesized that an individually defined 
targeted approach, based on structured clinical 
reasoning and including the results of three-
dimensional gait analysis, provides better results 
than a general program.
Method
Participants were selected through the cerebral 
palsy reference center of the University Hospital of 
Leuven. Inclusion criteria were diagnosis of bilat-
eral spastic cerebral palsy, Gross Motor Function 
Classification System Level I, II or III, age between 
four and nine years and sufficient cooperation to 
understand and execute simple verbal instructions. 
Patients were excluded when they showed severe 
muscle contractures or bony deformities, a history 
of multilevel orthopedic surgery or additional dis-
orders that would make participation to the physi-
cal therapy programs not feasible (e.g. severe 
cognitive disorders, deafness, blindness, etc.). The 
programs were planned at a time when children 
had not received botulinum-toxin A injections 
within the previous six months. A convenience 
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sample of 10 children represented a manageable 
number to reassure an adequate follow-up for this 
pilot study. Children were recruited between 
January 2010 and January 2012.
The programs were executed by the child’s per-
sonal physical therapist, who agreed to precisely 
follow the prescribed program. A physical therapy 
degree was required, no further specialization was 
mandatory. The therapist and parent or caretaker of 
the child signed an informed consent. The study 
was approved by the ethical committee of the 
University Hospital of Leuven.
At the start of the study, the selected group of 10 
children was followed for a period of 10 weeks of 
usual care. During this period, usual physical ther-
apy of the child was continued without a specific 
intervention. A diary was provided to document the 
content of the therapy sessions. The therapists were 
asked to fill in the diary after each session, to reg-
ister how much of the therapy time targeted the 
impairment, activity and participation level.
Subsequently, the children were enrolled in 
the actual intervention study. For this part of the 
study, an alternating treatment design with rand-
omization and cross-over was set up. A first treat-
ment program, general or individualized, was 
presented to the participants based on an inde-
pendent randomization procedure. Randomization 
was performed by a person blinded and inde-
pendent to the study, and was based on the prin-
ciples of minimization, as described by Altman 
and Bland.15 After completing one program, a 
wash-out period of minimally 10 weeks usual 
care was continued. Consequently, each child 
participated in the remaining program. The chil-
dren that originally received the individualized 
program, now received the general program and 
vice versa (Figure 1).
The general treatment program was based on 
the most common aims in children with bilateral 
spastic cerebral palsy of the involved age-range16 
and was the same for all children. The main aims 
were in accordance with the clinical management 
recommendations for children with spastic diplegia 
as stated by the task force of the American Physical 
Therapy Association.16 The general considerations 
reported in this statement, are musculoskeletal and 
neuromuscular systems including strength, range 
of motion, posture, balance, motor function, mus-
cle tone and movement patterns. The program, 
therefore, contained exercises to improve strength, 
selectivity and mobility and included a set of func-
tional exercises to encourage mobility and play.
The individually defined, targeted programs 
(further referred to as “individualized programs”) 
were designed to target the specific main problems 
of the child, tailored to the needs of the child and 
specific problems at the different levels of the ICF 
at that particular moment. Definition of the indi-
vidual problems was based on the results of all 
assessments. At the level of body structure and 
function, results of the clinical examination were 
considered. At activity level, three-dimensional 
gait analysis and gross motor function evaluation 
was used, complemented with a structured inter-
view with the parents and child. The results of the 
gait analysis thereby played a major role in unrave-
ling the motor problems of the child and the identi-
fication of the main problems. The programs were 
based on the clinical decision framework as 
described by Franki et al.,14 which use the ICF and 
the Hypothesis-Oriented Algorithm for Clinicians 
(HOAC-II)12 to identify a selection of main prob-
lems. This allowed goal-setting at all levels of the 
ICF, according to the needs of the child. The goals 
were discussed with the child’s parents or caretak-
ers, as well as the child’s physical therapist. The 
designs of the programs thereby approached the 
reality of clinical practice, using a mixture of indi-
vidual techniques, each targeting a specific prob-
lem of the child at that particular moment. The 
choice of the appropriate techniques to achieve a 
specific goal was performed according to the 
evidence-table designed by Franki et al. in previ-
ous systematic reviews.2,3 Table 1 provides an 
overview of the similarities and differences 
between the programs.
Participants were evaluated before and after the 
period of usual care, as well as after each treatment 
program using the gross motor function measure,17 
standardized clinical examination and three-
dimensional gait analysis.
The Gross Motor Function Measurement-88 is a 
standardized clinical instrument to evaluate change 
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Randomization
Pilot sample 
N=10 
Usual Care ( 10 weeks)
N= 10
Intervention 1:
General therapy program 
(10 weeks)
N=5
Intervention 1:
Individualized therapy program
(10 weeks)
N=5
Intervention 2:
General therapy program 
(10 weeks)
N=5
Intervention 2:
Individualized therapy program
(10 weeks)
N=5
Evaluation 1: 
GMFM-88
3DGA
Evaluation 2: 
GMFM-88
3DGA
Evaluation 3: 
GMFM-88
3DGA
Evaluation 4: 
GMFM-88
3DGA
Evaluation 5: 
GMFM-88
3DGA
Wash-out (minimally 10 weeks) + 
cross -over
Wash-out (minimally 10 weeks) + 
cross -over
Figure 1. Study design.
in gross motor function in children with cerebral 
palsy. It fulfills the criteria of reliability and valid-
ity with respect to responsiveness to change.18–20 
The gross motor function evaluations were per-
formed by the first author of this study, but video-
taped. Two independent assessors, blinded to the 
set-up of the study, scored the video. The average 
of both video-scores was used.
Clinical examination and three-dimensional 
gait analysis were performed according to the 
standardized protocol used at the Laboratory of 
Clinical Motion Analysis of the hospital. An inde-
pendent assessor, blinded to the study, performed 
both assessments. Clinical examination included 
measurements of range of motion (goniometrical 
measurements), spasticity (Modified Ashworth 
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Table 1. Differences and similarities between the general, aim-oriented program and the individually defined 
targeted programs.
General treatment program Individually defined, targeted treatment programs
Differences • The same program for all children.
•  Based on the most common problems of 
ambulant children with bilateral spastic 
cerebral palsy.
• Aspecific, based on general aims.
•  A predefined set of exercises to improve 
strength, selectivity and mobility and gross 
motor function.
•  The results of the three-dimensional gait 
analysis were not used to define of the 
program.
•  The program was not discussed with the 
therapist and parents.
• Different for all children.
•  Based on the results of the individual 
assessments.
• Specific, tailored to the individual problems.
• Goal-oriented.
•  Depending on the needs of the child, the 
exercises targeted the different levels of the 
ICF.
•  Based on structured clinical reasoning using 
the HOAC-II and the ICF.
•  The results of the three-dimensional gait 
analysis were included to define the program.
•  The program was discussed with the parents 
and the therapist.
Similarities •  Respected the basic principles for 
evidence-based physical therapy regarding 
intensity and repetitions:
  Stretching: 3 repetitions of 30 seconds;
   Strength was trained in series of 3 
times 12 to 15 repetitions;
   Functional exercises were not 
restricted in repetition number.
•  Executed by the child’s private physical 
therapist, familiar to the child.
•  At the child’s usual frequency and duration 
of therapy.
•  Respected the basic principles for evidence-
based physical therapy regarding intensity and 
repetitions:
  Stretching: 3 repetitions of 30 seconds;
   Strength was trained in series of 3 times 12 
to 15 repetitions;
   Functional exercises were not restricted in 
repetition number.
•  Executed by the child’s private physical 
therapist, familiar to the child.
• At the child’s usual frequency and duration of 
therapy.
ICF: International Classification of Functioning, Disability and Health; HOAC: Hypothesis-Oriented Algorithm for Clinicians.
Scale and Tardieu), selectivity (selective motor 
scale) and muscle strength (manual muscle test-
ing).21–23 For gait analysis, information on kine-
matics, kinetics and spatial-temporal data was 
collected by a 16-camera VICON system (Nexus 
PluginGait marker set, Oxford Metrics, Oxford, 
UK), two ATMI forceplates (Advanced Medical 
Technology, Inc, Watertown, MA, USA) and a 
16-channel electromyograpy (EMG) device (Zero-
Wire, Cometa, Milano, Italy). Three representa-
tive trials were selected. Specific gait parameters 
were automatically extracted using a custom-made 
Matlab graphical user interface (Mathworks®, 
Natick, MA, USA). The results of the children 
were compared with the means and standard devi-
ations of a reference group. Our reference data 
was based on the data obtained from a control 
group of 55 typically developing children, with a 
mean age of 10.94 years, range between the ages 
of four years and 18 years.
Outcome parameters were derived at two differ-
ent levels (Figure 2).
At a first, general level, overall therapy success 
was evaluated using outcome parameters that pro-
vide a general outcome description. From the 
Gross Motor Function Measure, the total and 
dimensional percentage scores were extracted. 
Regarding gait analysis, time and distance param-
eters, the Movement Analysis Profiles and the Gait 
Profile Score were calculated.24 The average scores 
from the left and right sides were used. The 
Movement Analysis Profiles were calculated as the 
root mean square error between the point-by-point 
comparison of the lower limb joint angle and the 
averaged joint angle of the reference group. 
Calculation of the average of all lower limb joint 
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angles results in the Gait Profile Score, which sum-
marizes the overall severity of gait pathology.24
Second, individual goal achievement was evalu-
ated before and after the programs.
For the individual, functional goals extracted 
from the Gross Motor Function Measure-88, the 
original version of the Goal Attainment Scale 
(GAS) was used, as developed by Kirusek et al.25 
and used in several pediatric rehabilitation stud-
ies.26,27 Before the start of the programs, individual 
goals based on specific goal items of the Gross 
Motor Function Measure-88, were formulated 
according to the specific, measurable, achievable, 
realistic/ relevant and timed (SMART)-principle.28 
A score between –2 and 2 was given depending on 
the goal achievement. Subsequently, a converted 
T-score and the percentage of achieved goals (⩾0) 
were calculated.
Individual goal achievement of the specific 
goals derived from gait analysis was evaluated 
using z-scores and proportional changes. As a first 
step, two to eight specific deviated gait parameters 
were identified as specific goals for each child. 
Each goal was represented by a relevant data point 
that was expected to improve, such as maxima, 
minima, range of motion and angles at specific 
events in the gait cycle. These data points were 
defined based on literature and by clinical experts in 
gait analysis of children with cerebral palsy.29,30 The 
parameters were converted into z-scores. A z-score 
represents the deviation from a reference group (z = 
(mean child – mean typical child)/standard devia-
tion (SD) typical child). To evaluate the z-scores, 
the absolute difference to zero, in either direction, 
was considered as an equal deviation from typical 
gait. Following standard clinical practice, we 
GMFM – 88
Total scores
Dimension scores
GAS (original version)
GPS and MAPS
Time – and distance 
parameters
z-scores
Individual level
Outcome 
parameters
General level
Outcome 
measurements GMFM - 88 3DGA
Figure 2. Outcome measurements and parameters.
3DGA: Three-Dimensional Gait Analysis; GAS: Goal Attainment Scale; GMFM-88: Gross Motor Function Measurement; GPS: Gait 
Profile Score; MAPS: Movement Assessment Profiles.
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assumed that a deviation greater than 1 could be 
considered as pathological. Therefore, all z-scores 
smaller than 1 were eliminated.29 Consequently, the 
median z-scores of the specific goals were calcu-
lated. Z-scores are non-dimensional and, therefore, 
allow the comparison of different parameters. 
Finally, the proportional change was calculated 
(proportional change = (|pre median z-score| – 
|postmedian z-score| / |premedian z-score|)). This 
percentage score allowed a description of therapy 
success. A positive proportional change described a 
successful therapy and a negative proportional 
change indicated an unsuccessful therapy. For the 
individually defined programs, these individual 
goals were taken into account to design the pro-
grams. For the general programs, the individual 
goals were only considered as outcome parameters, 
but not specifically taken into account to during the 
programs.
Statistical analyses were performed in different 
steps. First, other treatment modalities, including 
the use of orthosis, aquatic and horse-riding ther-
apy, during the different intervention periods were 
compared using a McNemar test. Similarly, differ-
ences in the frequency and duration of the physical 
therapy sessions were tested using the related- 
samples Wilcoxon Signed-Rank test. Secondly, the 
median and interquartile range (IQR) of all param-
eters before and after the programs were calculated 
as appropriate. A related-samples Wilcoxon signed 
rank analysis was applied to calculate within-group 
differences of pre- and postvalues. In order to eval-
uate the effect between the different interventions, a 
related-samples Friedman’s two-way analysis of 
variance by rank analysis with post-hoc related-
samples Wilcoxon signed rank analysis was applied. 
This analysis compared the difference scores of the 
outcome parameters (difference score = Pre – Post), 
further described as between-program differences.
All statistics were performed in SPSS 21 IBM 
SPSS Statistics for Windows, Version 21.0. (IBM 
Corp, Armonk, NY, USA).
Results
Patient characteristics, as well as duration, fre-
quency of therapy and the use of orthosis are 
reported in Table 2 and were not significantly dif-
ferent between the different periods.
The results of the diaries provided during the 
period of usual care show that 55.8% of therapy 
time was dedicated at impairment level. Thereby, 
22.5% (interquartile range (IQR) 16.7–28.6) tar-
geted joint mobility and muscle length and 33.3% 
(IQR 23.9–35.9) strength. A median of 48.1% (IQR 
35.6–54.8%) of therapy time was used to train 
activities. Only 1.55% (IQR 0–6.5%) of therapy 
time addressed specific participation restrictions.
The median total percentage scores of the Gross 
Motor Function Measure-88 showed only very 
limited and no significant changes, but a slight 
increase after the individualized program, from 
93.5 to 95.5% (Table 3).
Dimension D and E showed a slight decrease 
during the period of usual care, but an increase 
after the period of individualized therapy. 
Evaluating the between-program differences 
revealed no significance.
Considering time and distance parameters 
showed significant improvements on step and 
stride length (p = 0.022 and 0.017, respectively) 
after the period of individualized therapy. Between-
program effects were, therefore, also significant for 
step length in the advantage of the individualized 
therapy program (p = 0.045). Changes in Gait 
Profile Score and Movement Assessment Profile 
Scores are provided in Table 4. Significant changes 
were found after the individualized program, for 
the pelvis at the transversal plane (p = 0.047), while 
for the general program differences were found for 
the pelvis in the coronal plane (p = 0.047). Between-
program changes were only found for the knee in 
the sagittal plane and this in the advantage of the 
individualized therapy program (p = 0.047). The 
results of the Gait Profile Score showed slight pro-
gress after the individualized program, whereas 
deterioration was registered after the general pro-
gram. No changes were measured after the period 
of usual care.
Functional goal attainment was higher after the 
individualized than after the general therapy pro-
gram: 48.0 (IQR 43.3–59.3) compared with 43.5 
(IQR 30.3–43.5) (p = 0.285). Additionally, the 
averaged percentage of achieved goals was 50.0 
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Table 2. Patient characteristics.
Patient characteristics
Age (median + IQR) 6.2 years (4.6 – 7.0 years)
Gender (n) (male/female) 6/4
GMFCS (n) (I/II) 5/5
History of BTX-A injections (n) 4
 UC GT IT
Use of day orthosis (n)  
>50%/day 8 7 7
<50%/day 0 2 2
no 2 1 1
Use of night orthosis (n)  
>50%/night 1 2 0
<50%/night 0 2 4
no 9 6 6
Frequency of PT (times/week) Med (IQR) 2 (2–3) 3 (2–3) 3 (2–4)
Duration of PT (minutes/session) Med (IQR) 40 (30–60) 40 (30–60) 40 (30–60)
Total PT (minutes/week) 105 (80–120) 120 (90–128) 120 (90–123)
BTX-A: Botulinum Toxin A; GMFCS: Gross Motor Function Classification System; GT: period of general treatment; IQR: inter-
quartile range; IT: period of individualized, targeted treatment; PT: physical therapy; UC: period of usual care.
(IQR 25.0–100) after the individualized program, 
compared with 41.7 (IQR 0–75) for the general 
program (p = 0.589). Nevertheless, none of the 
programs caused treatment success (GAS ⩾50) 
and the differences were not statistically signifi-
cant. Table 5 provides an overview of the changes 
in z-scores for the goals derived from the gait anal-
ysis after both training periods. This analysis 
revealed a median difference in z-score (pre–post) 
of 0.279 and 0.419 after the period of general and 
individualized therapy program, respectively. This 
was translated in a proportional change of 12% and 
19%, respectively. These changes, however, were 
not significantly different.
Discussion
The effects of the present study demonstrated a ten-
dency in favor of the individually defined, targeted 
program on gait and gross motor function. On a 
general level, significant advantageous results were 
found for the individualized program on step length 
and for the movement assessment profiles of the 
knee in the sagittal plane. At an individual level, 
goal achievement was non-significantly higher 
after the individualized program compared with the 
general program, and this for both the functional 
goals as the goals based on gait analysis.
The applied approach was representative for the 
reality of clinical practice, which usually makes 
use of a mixture of individual techniques, each tar-
geting a specific problem. It differed from more 
recent goal-oriented, activity-focused interventions 
that usually apply a ‘top-down’ approach within 
the IFC.31 The clinical reasoning strategy used to 
define the individually tailored programs was 
based on a horizontal approach and, therefore, con-
sidered all dimensions of the model of equal impor-
tance. It aimed to specifically address the thoughts 
behind the dynamic and interactive concept of the 
ICF and, thereby, also the multidimensional diffi-
culties following cerebral palsy. Gait rehabilitation 
was an essential part of our programs and a large 
part of our outcome parameters consisted of gait 
measures. This was motivated by previous research 
that highlighted that both gait speed and the amount 
of gait pathology adversely affected quality of life, 
as reported by the child and their proxy.32 This 
unique but realistic concept can be considered as a 
major strength of our study.
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Table 5. Overview of the changes in z-scores and the converted proportional changes as derived from the 
individual goals based on the results of the three-dimension gait analysis.
Child General program Individualized program p (between)
 Pre Post Diff PC p (within) Pre Post Diff PC p (within)
1 2.967 3.142 –0.175 –6% 0.368 2.718 2.656 0.062 2% 0.169 0.333
2 1.646 1.184 0.462 28% 1.669 0.738 0.931 56%
3 2.334 1.576 0.759 33% 2.271 1.629 0.641 28%
4 3.093 2.475 0.618 20% 2.410 1.672 0.738 31%
5 1.592 2.026 –0.434 –27% 2.449 2.536 –0.088 –4%
6 1.439 0.747 0.693 48% 3.349 3.003 0.347 10%
7 1.485 0.741 0.744 50% 1.867 1.179 0.688 37%
8 1.472 1.886 –0.414 –28% 1.453 0.961 0.492 34%
9 2.134 2.038 0.096 4% 2.703 2.804 –0.101 –4%
10 3.263 4.127 –0.864 –26% 2.788 3.681 –0.893 –32%
50th (median) 1.889 1.817 0.278 12% 2.429 2.104 0.419 19%  
25th 1.481 1.070 –0.419 –27% 1.817 1.124 –0.090 –4%  
75th 2.990 2.641 0.705 36% 2.735 2.853 0.700 35%  
Diff: difference between the pre- and postvalue; p (within): p value for the within-group effects of the z-scores as provided by the 
Wilcoxon signed ranks test; p (between): p value for the evaluation of the between-program effects of the z-scores as provided by 
the Wilcoxon signed ranks analysis; PC: proportional change, calculated by (z pre – z post)/z pre.
Another strength of the study was the rand-
omized cross-over design, allowing comparison of 
individual changes. The length of the wash-out 
period, thereby, was the same as the duration of the 
program. Wash-out periods are required assuming 
that therapy effects are still present for a certain 
period after the intervention. In our recent system-
atic literature review, none of the studies using 
follow-up periods detected treatment effects last-
ing longer than the duration of the intervention 
itself.2 Additionally, in the current study, only the 
contents of the programs were adjusted and the 
researchers did not interfere with the frequency and 
duration of the programs. These considerations 
allowed us to be confident that a 10 weeks wash-
out period is sufficient to avoid overflow effects.
Nevertheless, only a limited number of param-
eters showed statistical significant changes. A first 
and major reason might be the small sample size. 
Although the set-up of the study was controlled 
and randomized, the sample size of 10 children 
provided low power. Post-hoc power calculation 
using SAS Power and Sample Size 3.1 (SAS insti-
tute Inc, Cary, NC, USA) revealed the gait profile 
score as being most vulnerable for the limited 
power. Considering a change score of 3° on the gait 
profile score as clinically relevant, provided 8% 
power. To be able to detect this change, future stud-
ies should use between 72 (80% power) to 91 par-
ticipants (90%). The Gross Motor Function 
Measure-88 was identified as least vulnerable for 
limited power. When using the Gross Motor 
Function Measure-88 as an outcome measure, 
future studies should use between 12 (80% power) 
to 15 participants (90%) to detect a change of 3%.
A second restriction might be related to the fact 
that both programs were executed by the child’s 
personal physical therapist. Besides the strict 
follow-up, influencing factors as cooperation of 
the therapist and correct execution of the programs 
still existed and were probably important con-
founding variables. The adequate follow-up could 
probably not completely control the correct appli-
ance and execution of the prescribed programs. 
During the period of usual care, regular physical 
therapy sessions were continued. Therefore, the 
contents of the programs were dependent of the 
physical therapist responsible for the child and a 
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large variation in therapy contents was possible. A 
diary was used to be able to monitor therapy con-
tents without interfering with the quality and con-
tents of therapy. Follow-up visits might have 
influenced therapy behavior and, therefore, diaries 
were preferred. Although the diary was a useful 
and objective tool, the physical therapists reported 
that filling the diary was time-consuming and 
caused a relatively large administrative burden. 
Therefore, diaries were avoided during the periods 
of interventions. The need for a diary during the 
periods of intervention was not strong as the pro-
grams were predefined using specific exercises. 
Therefore, follow-up during the interventions was 
performed using regular visits and phone-calls. 
Nevertheless, although the therapy programs were 
developed with more than 50% of the exercises 
targeting activity level, this did not necessary 
mean that therapy time was divided accordingly. 
Providing a diary during the periods of interven-
tions might have provided more precise insight 
into the follow-up of the programs.
A third limitation was the duration of the applied 
interventions. Ten weeks was a relatively short 
period to reach significant improvements. Guidelines 
by the National Strength and Conditioning 
Association stated that strength training should be 
applied 2–4 times a week on non-consecutive days 
for at least 8–20 weeks in order to find an increase in 
muscle strength.33 Therefore, a study of longer dura-
tion could have resulted in greater benefits. 
Additionally, longer-term studies allow an evaluation 
at participation level.34 As the study period of 
10 weeks was too short to expect significant changes 
at participation level, outcome evaluation did not 
include participation measures.34 Nonetheless, the 
design of the individualized integrated discussions 
with parents, children and therapists. In that way, 
individual participation limitations were considered 
during the development of the programs and were 
considered of equal value among the assessment 
measures when designing the programs.
Additionally, while the inclusion criteria 
allowed inclusion of children with Gross Motor 
Function Classification Level III, no children func-
tioning at this level could be included for this inter-
vention study. Children with Gross Motor 
Functional Classification Level III are more fre-
quently in need of tone-reduction by means of bot-
ulinum toxin and, therefore, we were not able to 
include these children during the predefined win-
dow of six months post-botulinum toxin.
The results demonstrated very limited differ-
ence but advantageous results of the interventions 
compared with the period of usual care. This might 
be explained by the variation in therapy as reported 
by the different therapists. Remarkably however, 
as all children were ambulant and thus very func-
tional, the percentage of time spent on impairment 
level (range between 40.3% and 70.3% of therapy 
time) was relatively high during the period of usual 
care. During the periods of intervention, the num-
ber of exercises targeting activity level was usually 
higher than 50%. Although this implies that during 
the interventions the average therapy time spent at 
activity level was probably higher than 50%, it 
might be a future recommendation to monitor ther-
apy time more accurately during the periods of 
intervention as well.
The proportional change scores allowed us to 
describe therapy success by explaining the gain or 
loss in performance. However, one needs to be 
careful with the interpretation of a proportional 
change score because it is easily influenced by 
extraneous factors (such as the standard deviation 
of the control group), and it may therefore overes-
timate outcome results.
The study results of the present study are concur-
rent with the previous experience of our research 
group, in which we evaluated the effectiveness of an 
individually defined approach.9 This study showed 
fundamental differences with the present study: the 
order of the programs was not randomized and they 
were of shorter duration (6 weeks). Additionally, the 
present structured clinical reasoning was not yet the 
basis for the individual programs.
The recent review by Brogren et al. concluded 
that the scientific evidence regarding goal-setting 
is inconclusive.10 Also, Law et al. could not find 
significant differences between a context-focused 
therapy containing goal-setting, and child and 
activity focused therapy without goal-setting.35 
However, these studies used goal-setting within an 
activity-focused approach only.
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This again supports our hypothesis that a suc-
cessful treatment approach is probably multifac-
torial and depends on several aspects like correct 
appliance of techniques, adequate goal and prior-
ity setting, frequency and duration of therapy, 
timely tone-reduction, attention for posture and 
positioning and maybe many others. Future 
research studies should probably continue to look 
for the effectiveness of individually tailored 
approaches addressing the heterogeneous nature 
of cerebral palsy, not only in individual goal-set-
ting, but also in the choice of techniques and 
approaches.
In conclusion, the results can only provide an 
indication of the additional value of goal-setting 
within an integrative approach. To confirm our 
hypothesis however, future studies should include 
sample sizes of minimally 72 participants, evaluate 
long-term effects and use individual goal-achieve-
ment measures.
Clinical messages
• In children with cerebral palsy, improve-
ments in gait and gross motor function 
showed a non-significant tendency to be 
greater after the use of an individualized 
rather than a general treatment program.
• A sample size of between 72 and 91 par-
ticipants is needed to confirm this ten-
dency, providing 80% and 90% power, 
respectively.
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